Stock LEVBIO ALPHAHELIX MOLECULAR DIAGNOSTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials AlphaHelix Molecular Diagnostics AB

Equities

LEVBIO

SE0000885501

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 16/05/2024 BST 		5-day change 1st Jan Change
0.32 SEK +3.23% Intraday chart for AlphaHelix Molecular Diagnostics AB +23.08% -21.57%
04-25 Level Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-22 AlphaHelix Molecular Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 49.66 17.43 67.1 162.9 47.3 25.87
Enterprise Value (EV) 1 51.7 19.35 66.88 158 40.05 23.34
P/E ratio -31.3 x -16.5 x 44.3 x 32.1 x -18.7 x -2.72 x
Yield - - - - - -
Capitalization / Revenue 2.74 x 1.02 x 2.85 x 3.71 x 1.38 x 0.99 x
EV / Revenue 2.85 x 1.13 x 2.84 x 3.59 x 1.17 x 0.89 x
EV / EBITDA -84.7 x -31.4 x 38 x 24.2 x -33.6 x -2.72 x
EV / FCF 89.3 x 43.7 x 48.6 x -204 x 11.4 x -12.5 x
FCF Yield 1.12% 2.29% 2.06% -0.49% 8.81% -8.03%
Price to Book 20.1 x 11.7 x 22.4 x 7.37 x 2.38 x 2.48 x
Nbr of stocks (in thousands) 52,832 52,832 52,832 63,399 63,399 63,399
Reference price 2 0.9400 0.3300 1.270 2.570 0.7460 0.4080
Announcement Date 30/04/19 04/05/20 04/05/21 03/05/22 02/05/23 26/03/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 18.13 17.08 23.53 43.96 34.33 26.1
EBITDA 1 -0.6105 -0.6164 1.759 6.518 -1.193 -8.578
EBIT 1 -1.184 -0.8738 1.549 5.258 -2.332 -9.732
Operating Margin -6.53% -5.12% 6.58% 11.96% -6.79% -37.3%
Earnings before Tax (EBT) 1 -1.339 -0.9727 1.521 5.213 -2.413 -9.694
Net income 1 -1.372 -0.9833 1.513 5.156 -2.224 -9.476
Net margin -7.57% -5.76% 6.43% 11.73% -6.48% -36.31%
EPS 2 -0.0300 -0.0200 0.0286 0.0800 -0.0400 -0.1500
Free Cash Flow 1 0.5792 0.4426 1.377 -0.7742 3.528 -1.874
FCF margin 3.19% 2.59% 5.85% -1.76% 10.28% -7.18%
FCF Conversion (EBITDA) - - 78.26% - - -
FCF Conversion (Net income) - - 90.97% - - -
Dividend per Share - - - - - -
Announcement Date 30/04/19 04/05/20 04/05/21 03/05/22 02/05/23 26/03/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 2.03 1.92 - - - -
Net Cash position 1 - - 0.22 4.96 7.24 2.52
Leverage (Debt/EBITDA) -3.332 x -3.115 x - - - -
Free Cash Flow 1 0.58 0.44 1.38 -0.77 3.53 -1.87
ROE (net income / shareholders' equity) -43.5% -49.7% 67.5% 41.1% -10.6% -62.5%
ROA (Net income/ Total Assets) -7.23% -5.81% 10.4% 15.7% -4.79% -25.4%
Assets 1 18.98 16.93 14.62 32.92 46.44 37.31
Book Value Per Share 2 0.0500 0.0300 0.0600 0.3500 0.3100 0.1600
Cash Flow per Share 2 0.0100 0.0100 0.0300 0.0900 0.1200 0.0600
Capex 1 0.05 - - - 0.07 0.04
Capex / Sales 0.3% - - - 0.21% 0.16%
Announcement Date 30/04/19 04/05/20 04/05/21 03/05/22 02/05/23 26/03/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
ALPHAHELIX MOLECULAR DIAGNOSTICS AB Stock AlphaHelix Molecular Diagnostics AB
-21.57% 1.84M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+12.15% 228B
DANAHER CORPORATION Stock Danaher Corporation
+14.90% 196B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+18.22% 141B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+29.15% 110B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.53% 65.88B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+16.92% 54.3B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+6.33% 52.39B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
+10.93% 45.22B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+5.87% 37.12B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. LEVBIO Stock
  4. Financials AlphaHelix Molecular Diagnostics AB